Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation

Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation

Direct oral anticoagulant (DOAC) use has significantly increased because major medical organizations endorse their role for conditions in which anticoagulation is indicated. Owing to important pharmacokinetic properties, the use of apixaban and rivaroxaban requires careful consideration in at-risk p...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas W. Lange, Justin Muir, David M. Salerno
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Kidney International Reports
Subjects:
apixaban
end-stage renal disease
rivaroxaban
Online Access:http://www.sciencedirect.com/science/article/pii/S246802492401982X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items